Skip to main content
TipRanks
Go Ultimate75% OFF

Vitro SAB de CV (VITOF) Stock Statistics & Valuation Metrics

4 Followers

Total Valuation

Vitro SAB de CV has a market cap or net worth of $129.28M. The enterprise value is $305.61T.

Market Cap
$129.28M
Enterprise Value
$305.61T

Share Statistics

Vitro SAB de CV has 483,571,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
483,571,400
Owned by Insiders
―
Owned by Institutions
0.09%

Financial Efficiency

Vitro SAB de CV’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 0.58%.

Return on Equity (ROE)
0.21
Return on Assets (ROA)
0.11
Return on Invested Capital (ROIC)
0.58%
Return on Capital Employed (ROCE)
0.01
Revenue Per Employee
13.31K
Profits Per Employee
6,116.976
Employee Count
22,568
Asset Turnover
0.23
Inventory Turnover
10.74

Valuation Ratios

The current PE Ratio of Vitro SAB de CV is 1.11. Vitro SAB de CV’s PEG ratio is 0.02.

PE Ratio
1.11
PS Ratio
0.95
PB Ratio
3.13
Price to FCF
0.78
Price to Operating Cash Flow
0.73
PEG Ratio
0.02

Income Statement

In the last 12 months, Vitro SAB de CV had revenue of 300.37M and earned 138.05M in profits. Earnings per share was 0.29.

Revenue
300.37M
Gross Profit
109.62M
Operating Income
6.20M
Pretax Income
160.92M
Net Income
138.05M
EBITDA
33.16M
Earnings Per Share (EPS)
0.29

Cash Flow

In the last 12 months, operating cash flow was 172.36M and capital expenditures -10.41M, giving a free cash flow of 161.95M billion.

Operating Cash Flow
172.36M
Free Cash Flow
161.95M
Free Cash Flow per Share
0.34

Dividends & Yields

Vitro SAB de CV pays an annual dividend of ―, resulting in a dividend yield of 568.83%

Dividend Per Share
―
Dividend Yield
568.83%
Payout Ratio
N/A
Free Cash Flow Yield
128.20%
Earnings Yield
90.24%

Stock Price Statistics

Beta
0.00
52-Week Price Change
0.00%
50-Day Moving Average
0.15
200-Day Moving Average
0.15
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Vitro SAB de CV upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date
Jul 26, 2024
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Vitro SAB de CV as a current ratio of 1.20, with Debt / Equity ratio of 23.69%

Current Ratio
1.20
Quick Ratio
1.16
Debt to Market Cap
1.02
Net Debt to EBITDA
4.07
Interest Coverage Ratio
0.17

Taxes

In the past 12 months, Vitro SAB de CV has paid 22.87M in taxes.

Income Tax
22.87M
Effective Tax Rate
0.14

Enterprise Valuation

Vitro SAB de CV EV to EBITDA ratio is 39.29, with an EV/FCF ratio of 1.09.

EV to Sales
1.33
EV to EBITDA
39.29
EV to Free Cash Flow
1.09
EV to Operating Cash Flow
1.03

Balance Sheet

Vitro SAB de CV has $11.00M in cash and marketable securities with $62.00M in debt, giving a net cash position of -$51.00M billion.

Cash & Marketable Securities
$11.00M
Total Debt
$62.00M
Net Cash
-$51.00M
Net Cash Per Share
-$0.11
Tangible Book Value Per Share
$0.08

Margins

Gross margin is 52.41%, with operating margin of -11.50%, and net profit margin of 85.78%.

Gross Margin
52.41%
Operating Margin
-11.50%
Pretax Margin
45.73%
Net Profit Margin
85.78%
EBITDA Margin
3.40%
EBIT Margin
-10.75%

Analyst Forecast

The average price target for Vitro SAB de CV is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
-52.70%
EPS Growth Forecast
79.72%